Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Arcus Biosciences, Inc. (RCUS) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$31.00M |
|
$-81.00M |
|
-- |
|
$31.00M |
|
$122.00M |
|
$-91.00M |
|
$11.00M |
|
$-80.00M |
|
$-80.00M |
|
$-81.00M |
|
$-81.00M |
|
$-81.00M |
|
$-81.00M |
|
$-91.00M |
|
$-94.00M |
|
74.00M |
|
74.00M |
|
$-1.08 |
|
$-1.08 |
|
| Balance Sheet Financials | |
$831.00M |
|
$51.00M |
|
$264.00M |
|
$1.09B |
|
$184.00M |
|
-- |
|
$449.00M |
|
$633.00M |
|
$462.00M |
|
$462.00M |
|
$462.00M |
|
75.50M |
|
| Cash Flow Statement Financials | |
$-306.00M |
|
$194.00M |
|
$33.00M |
|
$209.00M |
|
$130.00M |
|
$-79.00M |
|
$73.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.52 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-293.55% |
|
-293.55% |
|
-- |
|
-258.06% |
|
-261.29% |
|
$-330.00M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.82 |
|
110.32 |
|
-17.53% |
|
-17.53% |
|
-7.40% |
|
-17.53% |
|
$6.12 |
|
$-4.46 |
|
$-4.14 |
|